BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 33927387)

  • 1. Broadly neutralizing antibody cocktails targeting Nipah virus and Hendra virus fusion glycoproteins.
    Dang HV; Cross RW; Borisevich V; Bornholdt ZA; West BR; Chan YP; Mire CE; Da Silva SC; Dimitrov AS; Yan L; Amaya M; Navaratnarajah CK; Zeitlin L; Geisbert TW; Broder CC; Veesler D
    Nat Struct Mol Biol; 2021 May; 28(5):426-434. PubMed ID: 33927387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
    Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
    Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fc-Based Recombinant Henipavirus Vaccines Elicit Broad Neutralizing Antibody Responses in Mice.
    Li Y; Li R; Wang M; Liu Y; Yin Y; Zai X; Song X; Chen Y; Xu J; Chen W
    Viruses; 2020 Apr; 12(4):. PubMed ID: 32340278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prefusion stabilization of the Hendra and Langya virus F proteins.
    Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
    J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
    Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
    J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
    Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
    Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
    J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and design of Langya virus glycoprotein antigens.
    Wang Z; McCallum M; Yan L; Gibson CA; Sharkey W; Park YJ; Dang HV; Amaya M; Person A; Broder CC; Veesler D
    Proc Natl Acad Sci U S A; 2024 Apr; 121(16):e2314990121. PubMed ID: 38593070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines to Emerging Viruses: Nipah and Hendra.
    Amaya M; Broder CC
    Annu Rev Virol; 2020 Sep; 7(1):447-473. PubMed ID: 32991264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of neutralizing antibodies to Hendra and Nipah glycoproteins using a Venezuelan equine encephalitis virus in vivo expression system.
    Defang GN; Khetawat D; Broder CC; Quinnan GV
    Vaccine; 2010 Dec; 29(2):212-20. PubMed ID: 21050901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein.
    Dong J; Cross RW; Doyle MP; Kose N; Mousa JJ; Annand EJ; Borisevich V; Agans KN; Sutton R; Nargi R; Majedi M; Fenton KA; Reichard W; Bombardi RG; Geisbert TW; Crowe JE
    Cell; 2020 Dec; 183(6):1536-1550.e17. PubMed ID: 33306954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A potent Henipavirus cross-neutralizing antibody reveals a dynamic fusion-triggering pattern of the G-tetramer.
    Fan P; Sun M; Zhang X; Zhang H; Liu Y; Yao Y; Li M; Fang T; Sun B; Chen Z; Chi X; Chen L; Peng C; Chen Z; Zhang G; Ren Y; Liu Z; Li Y; Li J; Li E; Guan W; Li S; Gong R; Zhang K; Yu C; Chiu S
    Nat Commun; 2024 May; 15(1):4330. PubMed ID: 38773072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.
    Xu K; Rockx B; Xie Y; DeBuysscher BL; Fusco DL; Zhu Z; Chan YP; Xu Y; Luu T; Cer RZ; Feldmann H; Mokashi V; Dimitrov DS; Bishop-Lilly KA; Broder CC; Nikolov DB
    PLoS Pathog; 2013; 9(10):e1003684. PubMed ID: 24130486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
    Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
    J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
    Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.
    Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS
    J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development.
    Loomis RJ; Stewart-Jones GBE; Tsybovsky Y; Caringal RT; Morabito KM; McLellan JS; Chamberlain AL; Nugent ST; Hutchinson GB; Kueltzo LA; Mascola JR; Graham BS
    Front Immunol; 2020; 11():842. PubMed ID: 32595632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-Linked Immunosorbent Assay Using Henipavirus-Receptor EphrinB2 and Monoclonal Antibodies for Detecting Nipah and Hendra Viruses.
    Zhu W; Smith G; Pickering B; Banadyga L; Yang M
    Viruses; 2024 May; 16(5):. PubMed ID: 38793674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.